Bundamedik Tbk vs Multi Makmur Lemindo Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Multi Makmur Lemindo Tbk. trades at Rp125 (market cap 421.41B, 31.51M 24h volume). The key difference: Bundamedik Tbk is far larger — about 3.6× Multi Makmur Lemindo Tbk.'s market cap, and Multi Makmur Lemindo Tbk. is more actively traded (31.51M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | PIPA | |
|---|---|---|
Market Cap | 1.51T | 421.41B |
Volume | 536.7K | 31.51M |
Lot | 5.37K | 315.07K |
Turnover | 93.41M | 3.94B |
Average Price | 174.05 | 125.2 |
Value | 93.41M | 3.94B |
Indicative Equilibrium Price | 176 | 125 |
Indicative Equilibrium Volume | 100 | 6.99K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Multi Makmur Lemindo Tbk (the Company) was established based on Notarial Deed No. 66 dated January 11, 2012 of Deni Nugraha, S.E., S.H., M.Kn., notary in Tangerang. The Company started its commercial operations in 2005.
Read more on PIPA →